These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15542757

  • 21. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y, Ohno-Shosaku T, Kano M.
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [Abstract] [Full Text] [Related]

  • 22. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D, Lépicier P, Lagneux C, Bouchard JF.
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [Abstract] [Full Text] [Related]

  • 23. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS, Sim-Selley LJ.
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [Abstract] [Full Text] [Related]

  • 24. Neuromodulatory functions of the endocannabinoid system.
    Marsicano G, Lutz B.
    J Endocrinol Invest; 2006 Apr; 29(3 Suppl):27-46. PubMed ID: 16751707
    [Abstract] [Full Text] [Related]

  • 25. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA, Lutz B.
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [Abstract] [Full Text] [Related]

  • 26. Presynaptic modulation by endocannabinoids.
    Lovinger DM.
    Handb Exp Pharmacol; 2008 Jun; (184):435-77. PubMed ID: 18064422
    [Abstract] [Full Text] [Related]

  • 27. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.
    Steiner MA, Wotjak CT.
    Prog Brain Res; 2008 Jun; 170():397-432. PubMed ID: 18655899
    [Abstract] [Full Text] [Related]

  • 28. [Endocannabinoids in the central nervous system].
    Venance L, Maldonado R, Manzoni O.
    Med Sci (Paris); 2004 Jan; 20(1):45-53. PubMed ID: 14770363
    [Abstract] [Full Text] [Related]

  • 29. Latest advances in cannabinoid receptor agonists.
    Thakur GA, Tichkule R, Bajaj S, Makriyannis A.
    Expert Opin Ther Pat; 2009 Dec; 19(12):1647-73. PubMed ID: 19939187
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J, Budhiraja S.
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [Abstract] [Full Text] [Related]

  • 31. Modulation of brain endocannabinoid levels by voluntary alcohol consumption in alcohol-preferring AA rats.
    Malinen H, Lehtonen M, Hyytiä P.
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1711-20. PubMed ID: 19572983
    [Abstract] [Full Text] [Related]

  • 32. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.
    Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL.
    Biol Psychiatry; 2005 Mar 01; 57(5):480-6. PubMed ID: 15737662
    [Abstract] [Full Text] [Related]

  • 33. Role of endogenous cannabinoids in synaptic signaling.
    Freund TF, Katona I, Piomelli D.
    Physiol Rev; 2003 Jul 01; 83(3):1017-66. PubMed ID: 12843414
    [Abstract] [Full Text] [Related]

  • 34. [The modulatory role of endocannabinoids in sleep].
    Murillo-Rodríguez E.
    Rev Neurol; 2003 Jul 01; 46(3):160-6. PubMed ID: 18297624
    [Abstract] [Full Text] [Related]

  • 35. Endocannabinoids, metabolic regulation, and the role of diet.
    Carr TP, Jesch ED, Brown AW.
    Nutr Res; 2008 Oct 01; 28(10):641-50. PubMed ID: 19083471
    [Abstract] [Full Text] [Related]

  • 36. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
    Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR.
    Ann N Y Acad Sci; 2006 Aug 01; 1074():514-36. PubMed ID: 17105950
    [Abstract] [Full Text] [Related]

  • 37. Endocannabinoid system: An overview of its potential in current medical practice.
    Mouslech Z, Valla V.
    Neuro Endocrinol Lett; 2009 Aug 01; 30(2):153-79. PubMed ID: 19675519
    [Abstract] [Full Text] [Related]

  • 38. Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice.
    Kelaï S, Hanoun N, Aufrère G, Beaugé F, Hamon M, Lanfumey L.
    J Neurochem; 2006 Oct 01; 99(1):308-20. PubMed ID: 16987253
    [Abstract] [Full Text] [Related]

  • 39. Pharmacology of cannabinoids.
    Grotenhermen F.
    Neuro Endocrinol Lett; 2004 Oct 01; 25(1-2):14-23. PubMed ID: 15159677
    [Abstract] [Full Text] [Related]

  • 40. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM, Koethe D.
    Addict Biol; 2008 Jun 01; 13(2):264-75. PubMed ID: 18482435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.